Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II infant meningococcal A conjugate vaccine dose and schedule study with EPI vaccines in Ghana
ISRCTN82484612Phase 2Completed
- Sponsor
- Serum Institute of India
- Start
- Aug 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of MenAfriVac in meningococcal disease and bacterial meningitis (4 arms), sponsored by Serum Institute of India. Started Aug 2008; status: completed.
02
Drugs
MenAfriVac
03
Conditions
meningococcal diseasebacterial meningitis
Beyond the preview
Go deeper on ISRCTN82484612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN82484612.